Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency

Human Gene Therapy

Volumn 7, Issue 15, 1996, Pages 1813-1826

  Petrof, Basil J ^a,b   Lochmüller, Hanns ^c   Massie, Bernard ^d   Yang, Liying ^a,b   Macmillan, Carol ^e   Zhao, Ji En ^c   Nalbantoglu, Josephine ^c   Karpati, George ^c  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD8 ANTIGEN; GENE PRODUCT; NEUTRALIZING ANTIBODY;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNODEFICIENCY; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE REPRESSION; GENE TRANSFER; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; MUSCLE FORCE; MUSCLE FUNCTION; NONHUMAN; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSGENE; ULTRAVIOLET IRRADIATION; VIRUS INFECTIVITY; VIRUS RECOMBINANT; VIRUS TRANSCRIPTION;

ADENOVIRIDAE; ANIMALIA;

EID: 0029963688     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.15-1813     Document Type: Article

References (51)

1. ACSADI, G., JANI, A., HUARD, J., BLASCHUK, K., MASSIE, B., HOLLAND, P., LOCHMÜLLER, H., and KARPATI, G. (1994a). Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther. 1, 338-340.
2. ACSADI, G., JANI, A., MASSIE, B., SIMONEAU, M., HOLLAND, P., and KARPATI, G. (1994b). A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3, 579-584.
3. ACSADI, G., LOCHMÜLLER, H., JANI, A., HUARD, J., MASSIE, B., PRESCOTT, S., SIMONEAU, M., PETROF, B.J., and KARPATI, G. (1996). Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7, 129-140.
4. AHN, A.H., and KUNKEL, L.M. (1993). The structural and functional diversity of dystrophin. Nature Genet. 3, 283-291.
5. ALI, M., LEMOINE, N.R., and RING, C.J.A. (1994). The use of DNA viruses as vectors for gene therapy. Gene Ther. 1, 367-384.
6. BERKNER, K.L. (1988). Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6, 616-629.
7. BRUTKIEWICZ, R.R., and WELSH, R.M. (1995). Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J. Virol. 69, 3967-3971.
8. BUTTRICK, P.M., KASS, A., KITSIS, R.N., KAPLAN, M.L., and LEINWAND, L.A. (1992). Behavior of genes directly injected into the rat heart in vivo. Circ. Res. 70, 193-198.
9. CHROBOCZEK, J., BIEBER, F., and JACROT, B. (1992). The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186, 280-285.
10. COOVERT, D.D., and BURGHES, A.H.M. (1994). Gene therapy for muscle diseases. Curr. Opin. Neurol. 7, 463-470.
11. COTTEN, M., SALTIK, M., KURSA, M., WAGNER, E., MAASS, G., and BIRNSTIEL, M.L. (1994). Psoralen treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid. Virology 205, 254-261.
12. COX, G.A., COLE, N.M., MATSUMURA, K., PHELPS, S.F., HAUSCHKA, S.D., CAMPBELL, K.P., FAULKNER, J.A., and CHAMBERLAIN, J.S. (1993). Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364, 725-729.
13. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W.W., SARVETNICK, N., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
14. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
15. EPSTEIN, S.L., MISPLON, J.A., LAWSON, C.M., SUBBARAO, E.K., CONNORS, M., and MURPHY, B.R. (1993). β2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J. Immunol. 150, 5484-5493.
16. 2+. J. Physiol. 420, 337-353.
17. GILGENKRANTZ, H., DUBOC, D., JUILLARD, V., COUTON, D., PAVIRANI, A., GUILLET, J.G., BRIAND, P., and KAHN, A. (1995). Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response. Hum. Gene Ther. 6, 1265-1274.
18. GRESSENS, P., and MARTIN, J.R. (1994). HSV-2 DNA persistence in astrocytes of the trigeminal root entry zone: double labeling by in situ PCR and immunohistochemistry. J. Neuropathol. Exp. Neurol. 53, 127-135.
19. HIGUCHI, I., HASHIMOTO, K., KASHIO, N., IZUMO, S., INOSE, M., OHKUBO, R., NAKAGAWA, M., ARIMURA, K., and OSAME, M. (1995). Detection of HTLV-1 provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis. Muscle & Nerve 18, 854-858.
20. HOFFMAN, E.P., BROWN, R.H.J., and KUNKEL, L.M. (1987). Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
21. KAY, M.A., HOLTERMAN, A-X., MEUSE, L., GOWN, A., OCHS, H.D., LINSLEY, P.S., and WILSON, C.B. (1995). Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nature Gene. 11, 191-197.
22. LAMARCHE, N., MASSIE, B., RICHER, M., PARADIS, H., and LANGELIER, M. (1990). High level expression in 293 cells of herpes simplex virus type 2 ribonucleotide reductase 2 using an adenovirus vector. J. Gen. Virol 71, 1785-1792.
23. LEE, M.G., ABINA, M.A., HADDADA, H., and PERRICAUDET, M. (1995). The constitutive expression of the immunomodulatory gp 19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther. 2, 256-262.
24. LOCHMÜLLER, H., HUARD, A.J.J., PRESCOTT, S., SIMONEAU, M., MASSIE, B., KARPATI, G., and ACSADI, G. (1994). Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants during multiple passages in 293 cells. Hum. Gene Ther. 5, 1485-1491.
25. LOCHMÜLLER, H., PETROF, B.J., ALLEN, C., PRESCOTT, S., MASSIE, B., and KARPATI, G. (1995). Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic (mdx) mice. Biochem. Biophys. Res. Commun. 213, 569-574.
26. LOCHMÜLLER, H., PETROF, B.J., LAROCHELLE, N., DODELET, V., WANG, Q., ALLEN, C., PRESCOTT, S., MASSIE, B., NALBANTOGLU, J., and KARPATI, G. (1996). Transient immunosuppression by FK506 permits a sustained high level of dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther. 3, 706-716.
27. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8056-8063.
28. McCOY, R.D., DAVIDSON, B.L., ROESSLER, B.J., HUFFNAGLE, G.B., JANICH, S.L., LAING, T.J., and SIMON, R.H. (1995). Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6, 1533-1560.
29. MOSCOVICI, C., and MAISEL, J. (1958). A toxinlike material separable from type 5 adenovirus particles. Virology 6, 770-771.
30. NETER, J., WASSERMAN, W., and KUTNER, M.H. (1995). Applied Linear Statistical Models. (Richard D. Irwin, Inc., Homewood, IL).
31. PETROF, B.J., SHRAGER, J.B., STEDMAN, H.H., KELLY, A.M., and SWEENEY, H.L. (1993a). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710-3714.
32. PETROF, B.J., STEDMAN, H.H., SHRAGER, J.B., EBY, J., SWEENEY, H.L., and KELLY, A.M. (1993b). Adaptations in myosin heavy chain expression and contractile function in the dystrophic (MDX) mouse diaphragm. Am. J. Physiol. 265, C834-C841.
33. PETROF, B.J., ACSADI, G., JANI, A., MASSIE, B., BOURDON, J., MATUSIEWICZ, N., YANG, L., LOCHMÜLLER, H., and KARPATI, G. (1995). Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am. J. Respir. Cell Mol. Biol. 13, 508-517.
34. RAGOT, T., VINCENT, N., CHAFEY, P., VIGNE, E., GILGENKRANTZ, H., COUTON, D., CARTAUD, J., BRIAND, P., KAPLAN, J.C., PERRICAUDET, M., and KAHN, A. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650.
35. REICHEL, R., KOVESDI, I., and KEVINS, J.R. (1987). Developmental control of a promoter-specific factor that is also regulated by the E1A gene product. Cell 48, 501-506.
36. ROITT, I. (1994). Essential Immunology. (Backwell Scientific Publications, London).
37. SEN, G.C., and LENGYEL, P. (1992). The interferon system. A bird's eye view of its biochemistry. J Biol. Chem. 267, 5017-5020.
38. SETH, P., FITZGERALD, D., GINSBERG, H., WILLINGHAM, M., and PASTAN, I. (1984). Evidence that the penton base of adenovirus is involved in potentiation of toxicity of pseudomonas exotoxin conjugated to epidermal growth factor. Mol. Cell. Biol. 4, 1528-1533.
39. SPERGEL, J.M., HSU, W., AKIRA, S., THIMMAPPAYA, B., KISHIMOTO, T., and CHEN-KIANG, S. (1992). NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A. J. Virol. 66, 1021-1030.
40. STEDMAN, H.H., SWEENEY, H.L., SHRAGER, J.B., MAGUIRE, H.C., PANETTIERI, R.A., PETROF, B., NARUSAWA, M., LEFEROVICH, J.M., SLADKY, J.T., and KELLY, A.M. (1991). The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536-539.
41. TRIPATHY, S.K., GOLDWASSER, E., LU, M.-M., BARR, E., and LEIDEN, J.M. (1994). Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA 91, 11557-11561.
42. VAN GINKEL, F.W., LIU, C., SIMECKA, J.W., DONG, J.-Y., GREENWAY, T., FRIZZELL, R.A., KIYONO, H., McGHEE, J.R., and PASCUAL, D.W. (1995). Intratracheal gene delivery with adenovirus vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Hum. Gene Ther. 6, 895-903.
43. VINCENT, N., RAGOT, T., GILGENKRANTZ, H., COUTON, D., CHAFEY, P., GREGOIRE, A., BRIAND, P., KAPLAN, J.C., KAHN, A., and PERRICAUDET, M. (1993). Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5, 130-134.
44. WAGNER, E., ZATLOUKAL, K., COTTON, M., KIRLAPPOS, H., MECHTLER, K., CURIEL, D., and BRINSTIEL, M. (1992). Coupling of adenovirus to transferrin-polylsine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA 89, 6099-6103.
45. WILLIAMS, D.A., HEAD, S.I., LYNCH, G.S., and STEPHENSON, D.G. (1993). Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice. J. Physiol. 460, 51-67.
46. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994a). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
47. YANG, Y., NUNES, F.A., BERENSCI, K., GONCZOL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994b). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Gene. 7, 362-369.
48. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995a). Cellular and humoral immune response to viral antigens create barriers to lung-directed gene therapy with recombinant adenovirus. J. Virol. 69, 2004-2015.
49. YANG, Y., XIANG, Z., ERTL, H.C.J., and WILSON, J.M. (1995b). Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92, 7257-7261.
50. ZAJAC, A.J., MULLER, D., PEDERSON, K., FRELINGER, J.A., and QUINN, D.G. (1995). Natural killer cell activity in lymphocytic choriomeningitis virus-infected β2-microglobulin-deficient mice. Int. Immunol. 7, 1545-1556.
51. + cytolytic T cells. Nature 344, 742-746.